Insulet | صافي الدخل



Net Income تغيير تاريخ
Abbott USD 1.33B 7.9B 2025-03
Align Technology USD 93.23M 10.58M 2025-03
AtriCure USD -6747000 8.82M 2025-03
Avanos Medical USD 6.6M 403.9M 2025-03
Baxter International USD 126M 638M 2025-03
Becton, Dickinson and Co. USD 308M 5M 2025-03
Boston Scientific USD 674M 108M 2025-03
Cardinal Health USD 506M 106M 2025-03
Cooper Companies USD 104.3M 13.2M 2025-01
Dexcom USD 105.4M 46.3M 2025-03
Edwards Lifesciences USD 358M 27.6M 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Globus Medical USD 75.46M 48.96M 2025-03
ICU Medical USD -23828000 9.15M 2024-12
Insulet USD 35.4M 65.3M 2025-03
Integra LifeSciences USD -25293000 44.73M 2025-03
J&J USD 11B 7.57B 2025-03
Masimo USD -170700000 178.9M 2025-03
Medtronic USD 1.06B 237M 2025-04
Merit Medical Systems USD 30.15M 2.2M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Solventum Corp 137M 106M 2025-03
Stryker USD 654M 108M 2025-03
Tandem Diabetes Care USD -130556000 131.31M 2025-03
Teleflex USD 95M 231.66M 2025-03
West Pharmaceutical Services USD 89.8M 40.3M 2025-03
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12



Insulet صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.